C Edwards1, L Fearfield1,2. Show Affiliations » 1. Dermatology Department, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. 2. Dermatology Department, Royal Marsden Hospital, London, UK.
Abstract
Entities: Chemical Disease Species
Mesh： See more » AgedAlitretinoinAntibodies, Monoclonal/adverse effectsAntineoplastic Agents/therapeutic useDrug Eruptions/drug therapyDrug Eruptions/etiologyHumansLichenoid Eruptions/chemically inducedLichenoid Eruptions/drug therapyMaleNail Diseases/chemically inducedNail Diseases/drug therapyNivolumabProgrammed Cell Death 1 Receptor/antagonists & inhibitorsTretinoin/therapeutic use
Substances： See more » Antibodies, MonoclonalAntineoplastic AgentsProgrammed Cell Death 1 ReceptorAlitretinoinNivolumabTretinoin
Year: 2018 PMID： 29453770 DOI： 10.1111/ced.13410
Source DB: PubMed Journal: Clin Exp Dermatol ISSN： 0307-6938 Impact factor: 3.470